Mark Nathan Lampert, Biotechnology Value

About Mark Nathan Lampert

Mark Nathan Lampert, founder of the Biotechnology Value Fund (BVF), invests primarily in small-cap biotechnology companies (market caps $100M–$1B) using a value-oriented thesis that targets undervalued assets with strong scientific or clinical potential. His firm builds concentrated, long-term equity positions in early-stage drug development and clinical-stage biopharma, often engaging constructively with management to unlock value. Notable portfolio companies include Blueprint Medicines, Kymera Therapeutics, Xencor, Molecular Partners, and ChemoCentryx, with Kymera (KYMR) representing his largest holding at $458.3M as of Q1 2026. While BVF is primarily a hedge fund focused on public securities, it also participates in private venture rounds, such as a $52M Series A investment in Third Arc Bio in February 2026.

Mark Nathan Lampert at a glance

Role

Managing Director

Organization

Biotechnology Value Fund

Location

San Francisco, California, United States

Investor type

Venture Capital

Frequently asked about Mark Nathan Lampert

What does Mark Nathan Lampert invest in?

We have not verified a stated sector or stage focus for Mark Nathan Lampert at Biotechnology Value Fund (San Francisco, California, United States). The profile lists the organization, location and investors we track alongside them.

How do I contact Mark Nathan Lampert?

Mark Nathan Lampert's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.

Where is Mark Nathan Lampert based?

Mark Nathan Lampert is based in San Francisco, California, United States.

Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in San Francisco.

Investors similar to Mark Nathan Lampert (20)

• Andrew Chen
• Roham Gharegozlou
• Pete Fisher
• Barney Pell
• Josh Buckley
• Louis Beryl
• John Thompson
• Christopher Harris
• Elad Gil
• Bobby Goodlatte
• Ryan Petersen
• Tom Quimby
• Ryan Hoover
• Auren Hoffman
• David G. DeWalt
• Trevor Wright
• Greg Galligan
• Pamela Vagata
• Frederic Kerrest
• Kevin Lin

Browse related investor lists (2)

• Investors in San Francisco, California, United States
• Venture Capital investors

Compare Mark Nathan Lampert (8)

• Mark Nathan Lampert vs Andrew Chen
• Mark Nathan Lampert vs Roham Gharegozlou
• Mark Nathan Lampert vs Pete Fisher
• Mark Nathan Lampert vs Barney Pell
• Mark Nathan Lampert vs Josh Buckley
• Mark Nathan Lampert vs Louis Beryl
• Mark Nathan Lampert vs John Thompson
• Mark Nathan Lampert vs Christopher Harris

Investors like Mark Nathan Lampert · Full investor directory · Investor access · Company funding database